[1]赵 寻,朱家旺,张晓磊.支气管哮喘患者血清sICAM-1、IL-2、IL-4及HP变化及与肺功能的关系[J].医学信息,2021,34(11):105-107.[doi:10.3969/j.issn.1006-1959.2021.11.028]
 ZHAO Xun,ZHU Jia-wang,ZHANG Xiao-lei.Changes of Serum sICAM-1,IL-2,IL-4 and HP in Patients with Bronchial Asthma and Their Relationship with Lung Function[J].Medical Information,2021,34(11):105-107.[doi:10.3969/j.issn.1006-1959.2021.11.028]
点击复制

支气管哮喘患者血清sICAM-1、IL-2、IL-4及HP变化及与肺功能的关系()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年11期
页码:
105-107
栏目:
论著
出版日期:
2021-06-01

文章信息/Info

Title:
Changes of Serum sICAM-1,IL-2,IL-4 and HP in Patients with Bronchial Asthma and Their Relationship with Lung Function
文章编号:
1006-1959(2021)11-0105-03
作者:
赵 寻朱家旺张晓磊
(天津中医药大学第二附属医院急症科,天津 300150)
Author(s):
ZHAO XunZHU Jia-wangZHANG Xiao-lei
(Department of Emergency Medicine,the Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300150,China)
关键词:
支气管哮喘可溶性细胞间黏附分子-1白细胞介素-2白细胞介素-4羟舖氨酸肺功能
Keywords:
Bronchial asthmaSoluble intercellular adhesion molecule-1Interleukin-2 Interleukin-4HydroxyplastineLung function
分类号:
R562.2+5
DOI:
10.3969/j.issn.1006-1959.2021.11.028
文献标志码:
A
摘要:
目的 探讨支气管哮喘患者血清可溶性细胞间黏附分子-1(sICAM-1)、白细胞介素-2(IL-2)、白细胞介素-4(IL-4)、羟舖氨酸(HP)的变化与患者肺功能的关系。方法 选取2017年1月~2019年8月我院确诊的支气管哮喘患者120例设为哮喘组,健康体检对象60名设为对照组,比较两组血清sICAM-1、IL-2、IL-4、HP水平及肺功能指标[第1秒用力呼气容积(FEV1)、用力肺活量(FVC)、最大呼气峰值流速(PEF)],并分析哮喘组不同病情患者sICAM-1、IL-2、IL-4、HP水平,采用Pearson线性相关分析sICAM-1、IL-2、IL-4、HP水平及肺功能指标的关系。结果 哮喘组sICAM-1、IL-4及HP水平高于对照组,IL-2低于对照组,差异有统计学意义(P<0.05)。哮喘组FEV1、FVC、PEF低于对照组,差异有统计学意义(P<0.05)。急性发作期哮喘患者sICAM-1、IL-4及HP水平高于缓解期患者,IL-2水平低于缓解期患者(P<0.05)。Pearson线性相关分析显示,急性期哮喘患者sICAM-1、IL-4及HP水平与FEV1、FVC、PEF均呈负相关,而IL-2水平与FEV1、FVC、PEF呈正相关(P<0.05)。结论 支气管哮喘患者血清sICAM-1、IL-4及HP水平升高,IL-2水平降低,其引起的气道炎性表现与患者肺功能受损程度有关。
Abstract:
Objective To investigate the changes of serum soluble intercellular adhesion molecule-1 (sICAM-1), interleukin-2 (IL-2), interleukin-4 (IL-4) and hydroxyplastine (HP) in patients with bronchial asthma The relationship with the patient’s lung function.Methods A total of 120 patients with bronchial asthma diagnosed in our hospital from January 2017 to August 2019 were selected as the asthma group, and 60 healthy subjects were selected as the control group.Compare the two groups of serum sICAM-1, IL-2, IL-4, HP levels and lung function indicators [forced expiratory volume in the first second (FEV1), forced vital capacity (FVC), maximum peak expiratory flow rate (PEF)],and analyze the levels of sICAM-1, IL-2, IL-4, and HP in patients with different conditions in the asthma group.Pearson linear correlation was used to analyze the relationship among sICAM-1, IL-2, IL-4, HP levels and lung function indexes.Results The levels of sICAM-1, IL-4 and HP in the asthma group were higher than those in the control group, and IL-2 was lower than the control group, the difference was statistically significant (P<0.05).The FEV1, FVC and PEF of the asthma group were lower than those of the control group,the difference was statistically significant (P<0.05).The levels of sICAM-1, IL-4 and HP in patients with acute exacerbation were higher than those in remission, and the levels of IL-2 were lower than those in remission (P<0.05).Pearson linear correlation analysis showed that sICAM-1, IL-4, and HP levels in acute asthma patients were negatively correlated with FEV1, FVC, and PEF, while IL-2 levels were positively correlated with FEV1, FVC, and PEF (P<0.05).Conclusion The serum levels of sICAM-1, IL-4, and HP in patients with bronchial asthma are increased, while the level of IL-2 is decreased. The airway inflammation caused by them is related to the degree of lung function impairment.

参考文献/References:

[1]Alruwaili MF,Elwan A.Prevalence of asthma among male 16 to 18-year-old adolescents in the Northern Borders Region of Saudi Arabia[J].Electronic Physician,2018,10(6):6920-6926. [2]阮福旺,杨万勇,陈波.COPD和哮喘患者血清与支气管灌洗液中IL-8,SLPI,sCD14和sICAM-1含量比较[J].湖南师范大学学报(医学版),2016,26(3):116-120. [3]杨晨羲,宣桂琪,阮晓琳,等.哮喘模型大鼠肺组织中IL-4、IFN-γ的变化及防哮方的干预作用[J].中国中医急症,2018,27(2):212-214. [4]张焕英,于连峰,杨俊玲.支气管哮喘患者血清肿瘤坏死因子-α和透明质酸及羟脯氨酸水平表达及意义[J].中华实用诊断与治疗杂志,2016,30(10):1022-1024. [5]中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南(支气管哮喘的定义、诊断、治疗和管理方案)[J].中华结核和呼吸杂志,2008,31(3):177-185. [6]Turner RM,Depietro M,Ding B.Overlap of Asthma and Chronic Obstructive Pulmonary Disease in Patients in the United States:Analysis of Prevalence,Features,and Subtypes[J].JMIR Public Health and Surveillance,2018,4(3):60-64. [7]Moon H,Kim Y,Kwak Y,et al.Association between smoking type and prevalence of atopic dermatitis and asthma in men and women[J].International Journal of Nursing Practice,2018,45(7):680-683. [8]Fazlollahi MR,Najmi M,Fallahnezhad M,et al.Pediatric Asthma Prevalence:The First National Population-based Survey in Iran[J].The Clinical Respiratory Journal,2018,32(7):103-106. [9]梁庆标,林县杰.支气管哮喘血清中可溶性细胞间黏附分子、白细胞介素-8的变化及意义[J].泰山医学院学报,2016,37(7):754-755. [10]张晶,赖飞,梁小亮.支气管哮喘患者治疗前后血清IL-2、IL-4及外周全血T细胞亚群水平动态变化的研究[J].中国现代医学杂志,2016,26(19):69-74. [11]韩继红,肖丽,都雯,等.新疆地区支气管哮喘患者IL-4基因甲基化的研究[J].新疆医科大学学报,2017,40(9):1191-1194. [12]赵青.可溶性toll样受体参与颗粒物质诱导的炎症反应[J].中日友好医院学报,2015,29(4):251-253. [13]杨浩,李蕊.哮喘患儿体内EOS、IgE、IL-4及IFN-γ水平的检测及临床意义[J].中国妇幼健康研究,2015,26(3):573-575. [14]张海蓉,姜孝芳,高丽.新疆维吾尔族与汉族哮喘患者外周血CD4+T淋巴细胞白介素2、白介素4、干扰素γmRNA表达水平研究[J].中国全科医学,2016,19(16):1911-1916. [15]张海蓉,曾穗茹,高丽,等.哮喘患儿血浆IL-4、IFN-γ、SIgE表达及其与肺功能的相关性研究[J].新疆医科大学学报,2015,38(12):1486-1488.

相似文献/References:

[1]焦龙龙,郭悦鹏.初诊哮喘患者的呼出气一氧化氮与大小气道功能的 相关性及临床价值分析[J].医学信息,2018,31(06):70.[doi:10.3969/j.issn.1006-1959.2018.06.022]
 JIAO Long-long,GUO Yue-peng.Correlation and Clinical Value Analysis of Exhaled Nitric Oxide and Airway Function in Patients with Newly Diagnosed Asthma[J].Medical Information,2018,31(11):70.[doi:10.3969/j.issn.1006-1959.2018.06.022]
[2]刘玉振.孟鲁司特治疗支气管哮喘的临床研究[J].医学信息,2018,31(10):140.[doi:10.3969/j.issn.1006-1959.2018.10.047]
 LIU Yu-zhen.Clinical Study of Montelukast in the Treatment of Bronchial Asthma[J].Medical Information,2018,31(11):140.[doi:10.3969/j.issn.1006-1959.2018.10.047]
[3]井庆彦.治未病三伏贴对支气管哮喘缓解期患者 冬病夏治的疗效观察[J].医学信息,2018,31(17):143.[doi:10.3969/j.issn.1006-1959.2018.17.045]
 JING Qing-yan.Therapeutic Effect of Preventive Treatment of Disease of Sanfu Paster on Summer Treatment of Winter Disease in Patients with Bronchial Asthma[J].Medical Information,2018,31(11):143.[doi:10.3969/j.issn.1006-1959.2018.17.045]
[4]赵 静,陈华琴,张 宁,等.血清骨膜蛋白和脂联素联检诊断儿童支气管哮喘价值研究[J].医学信息,2018,31(21):71.[doi:10.3969/j.issn.1006-1959.2018.21.019]
 ZHAO Jing,CHEN Hua-qin,ZHANG Ning,et al.Diagnostic Value of Serum Periosteal Protein and Adiponectin in Children with Bronchial Asthma[J].Medical Information,2018,31(11):71.[doi:10.3969/j.issn.1006-1959.2018.21.019]
[5]王晓燕,梁 萍,董艳婷.非特异性免疫疗法在支气管哮喘治疗中的应用进展[J].医学信息,2019,32(05):57.[doi:10.3969/j.issn.1006-1959.2019.05.018]
 WANG Xiao-yan,LIANG Ping,DONG Yan-ting.Progress in the Application of Non-specific Immunotherapy in the Treatment of Bronchial Asthma[J].Medical Information,2019,32(11):57.[doi:10.3969/j.issn.1006-1959.2019.05.018]
[6]孟琳非,黄伟健,酆孟洁,等.基于聚类分析对慢性肺部疾病表型的研究进展[J].医学信息,2019,32(07):44.[doi:10.3969/j.issn.1006-1959.2019.07.015]
 MENG Lin-fei,HUANG Wei-jian,FENG Meng-jie,et al.Advances in Research on Phenotypes of Chronic Lung Diseases Based on Cluster Analysis[J].Medical Information,2019,32(11):44.[doi:10.3969/j.issn.1006-1959.2019.07.015]
[7]韦春峥,莫 彬,莫善圆,等.孟鲁司特钠联合布地奈德治疗儿童支气管哮喘合并变应性鼻炎的临床效果[J].医学信息,2019,32(20):142.[doi:10.3969/j.issn.1006-1959.2019.20.044]
 WEI Chun-zheng,MO Bin,MO Shan-yuan,et al.Clinical Effect of Montelukast Sodium Combined with Budesonide in the Treatment of Children with Bronchial Asthma Complicated with Allergic Rhinitis[J].Medical Information,2019,32(11):142.[doi:10.3969/j.issn.1006-1959.2019.20.044]
[8]易晓明,彭小娜.氧气驱动雾化吸入对支气管哮喘患者肺功能及血氧饱和度的影响[J].医学信息,2019,32(23):110.[doi:10.3969/j.issn.1006-1959.2019.23.030]
 YI Xiao-ming,PENG Xiao-na.Effect of Oxygen-Driven Aerosol Inhalation on Lung Function and Oxygen Saturation in Patients with Bronchial Asthma[J].Medical Information,2019,32(11):110.[doi:10.3969/j.issn.1006-1959.2019.23.030]
[9]王启龙,张 蔚.支气管哮喘急性发作并肺部感染患者血清炎性因子、免疫球蛋白水平与预后的相关性分析[J].医学信息,2021,34(22):81.[doi:10.3969/j.issn.1006-1959.2021.22.024]
 WANG Qi-long,ZHANG Wei.Correlation Analysis of Serum Inflammatory Factors, Immunoglobulin Levels and Prognosis in Patients with Acute Exacerbation of Bronchial Asthma Complicated with Pulmonary Infection[J].Medical Information,2021,34(11):81.[doi:10.3969/j.issn.1006-1959.2021.22.024]
[10]丁晓燕,丁惠芳.支气管哮喘患儿缓解期呼出气一氧化氮水平与肺功能的相关性研究[J].医学信息,2021,34(24):68.[doi:10.3969/j.issn.1006-1959.2021.24.014]
 DING Xiao-yan,DING Hui-fang.Correlation Between Respiratory Nitric Oxide Level and Lung Function in Children with Bronchial Asthma During Remission Period[J].Medical Information,2021,34(11):68.[doi:10.3969/j.issn.1006-1959.2021.24.014]

更新日期/Last Update: 1900-01-01